Counterfeit medicines in Cambodia - Possible causes

Pharmaceutical Research

Volumn 28, Issue 3, 2011, Pages 484-489

  Khan, Mohiuddin Hussain ^a   Okumura, Junko ^a,b   Sovannarith, Tey ^c   Nivanna, Nam ^c   Nagai, Hiroto ^a,d   Taga, Masatoshi ^a   Yoshida, Naoko ^a   Akazawa, Manabu ^a,e   Tanimoto, Tsuyoshi ^f   Kimura, Kazuko ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c Ministry of Health Cambodia   (Cambodia)

^d Komatsu Kaiei Pharmacy   (Japan)

^e MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^f DOSHISHA WOMEN'S COLLEGE OF LIBERAL ARTS   (Japan)

Author keywords

Cambodia; counterfeit medicine; developing country; factors; quality

Indexed keywords

ALBENDAZOLE; AMOXICILLIN; AMPICILLIN; ARTESUNATE; CEFALEXIN; CHLOROQUINE; COUNTERFEIT DRUG; DRUG; MEBENDAZOLE; METRONIDAZOLE; PARACETAMOL; UNCLASSIFIED DRUG;

CAMBODIA; CONTROLLED STUDY; DRUG CONTROL; DRUG QUALITY; DRUG RESEARCH; FOOD AND DRUG ADMINISTRATION; NOTE; PHARMACY; PREVALENCE; PRIORITY JOURNAL; REGISTRATION; WORLD HEALTH ORGANIZATION;

CAMBODIA; COUNTERFEIT DRUGS; FRAUD; HUMANS;

EID: 79952489255     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0289-1     Document Type: Note

References (13)

1. Wertheimer AI, Norris J. Safeguarding against substandard/counterfeit drugs: mitigating a macroeconomic pandemic. Res Soc Adm Pharm. 2009;5:4-16.
2. White N. Antimalarial drug regsistance and combination chemotherapy. Philos T Roy Soc B. 1999;354:739-49. (Pubitemid 29365622)
3. Hanif M, Mobarak MR, Ronan A, Rahman D, Donovan Jr JJ, Bennish ML. Fatal renal failure caused by diethylene glycol in paracetamol elixir: the Bangladesh epidemic. Br Med J. 1995;311:88-91.
4. WHO. Medicines: Counterfeit medicines. Geneva: World Health Organization; 2010 [cited 2010 8 March]; Fact sheet No. 275]. Available from: http://www.who.int/mediacentre/factsheets/fs275/en/index.html.
5. Ministry of Health. Study report on counterfeit and substandard drugs in Cambodia. Phnom Penh, 2001, 2004.
6. Lon CT, Tsuyuoka R, Phanouvong S, Nivanna N, Socheat D, Sokhan C, et al. Counterfeit and substandard antimalarial drugs in Cambodia. Trans R Soc Trop Med Hyg. 2006;100:1019-24. (Pubitemid 44334726)
7. Yang D, Plianbangchang P, Visavarungroj N, Rujivipat S. Quality of pharmaceutical items available from drugstores in Phnom Penh, Cambodia. Southeast Asian J Trop Med Public Health. 2004;35:741-7. (Pubitemid 39486452)
8. Khan MH, Okumura J, Sovannarith T, Nivanna N, Akazawa M, Kimura K. Prevalence of counterfeit anti-helminthic medicines: a cross-sectional survey in Cambodia (doi:10.1111/j.1365-3156.2010.02494.X). Trop Med Int Health. 2010;15:639-44.
9. Anonymous. Situational analysis pharmaceutical sector in Cambodia. Phnom Penh2004 [updated 10 Jun 2009; cited 2009 28 September]; 1 Jun 2003:[Available from: http://rc.racha.org.kh/docDetails.asp?resourceID=339&categoryID=19.
10. Meyn C. Drugs sector outpacing regulation. The Phnom Penh Post.
11. Khan MH, Okumura J, Sovannarith T, Nivanna N, Akazawa M, Kimura K. Prevalence of counterfeit anti-helminthic medicines: a cross-sectional survey in cambodia (doi:10.1111/j.1365-3156.2010.02494.X). Trop Med Int Health. 2010;15:639-44.
12. Hall KA, Newton PN, Green MD, De Veij M, Vandenabeele P, Pizzanelli D, et al. Characterization of counterfeit artesunate antimalarial tablets from Southeast Asia. Am J Trop Med Hyg. 2006;75:804-11. (Pubitemid 351627522)
13. Gaudiano M, Di Maggio A, Cocchieri E, Antoniella E, Bertocchi P, Alimonti S, et al. Medicines informal market in Congo, Burundi and Angola: Counterfeit and sub-standard antimalarials. Malar J. 2007;6:22.